Some patients face hurdles getting HIV prevention drugs. Here's what to know

NPR | December 22, 2025

Updates to the ?Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV

HIV.gov | September 26, 2025

Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries

Reuters | July 9, 2025

FDA approves twice-yearly capsid inhibitor for HIV prevention

Nature | July 8, 2025

HIV.gov | June 12, 2025

If Twice-Yearly Lenacapavir Could Be a HIV PrEP Game Changer, Would a Once-Yearly Version Be a HIV Epidemic Ender?

Managed Healthcare Executive | March 13, 2025

Gilead data suggests once-yearly shot of PrEP drug blocks HIV infection

STAT News | March 11, 2025

U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review

Gilead | February 18, 2025

This is what happens to the body when HIV drugs are stopped for millions of people

AP | February 13, 2025

Single-Tablet BIC/LEN Shows Good Results in Phase 3 for HIV Treatment

IDSE | January 16, 2026

New Once Weekly Investigational Oral Regimen Shows Strong 48 Week Results, Highlighting the Need for Easier HIV Treatment Options

UNC School of Medicine | January 16, 2026

Prior authorization and HIV medications: Considerations for state policymakers

hivma | January 16, 2026

Studies show that less frequent, all-injectable treatment for HIV is safe and preferred by adolescents

St Jude Children’s Research Hospital | January 15, 2026

PrEP Offers Everyone Protection From HIV

Cleveland Clinic | January 14, 2026

HIV infection Prevention in 2026: How PrEP Can Almost Eliminate Your HIV Risk

Doral Health & Wellness | January 13, 2026

Charity report urges government to commission PrEP through pharmacies

ThePhamaJournal | January 2, 2026

A new once-weekly duo for HIV treatment shows promising results

TPAN | December 23, 2025

GSK enters agreement with U.S. government to lower drug prices and expand access to ... 

ViiV Healthcare | December 19, 2025

[Press release] MHRA approves lenacapavir for the prevention of sexually transmitted HIV-1 infection 

European AIDS Treatment Group | December 19, 2025

Subcutaneous Lenacapavir in People with Multidrug-Resistant HIV-1: 156 Week Results of ... 

Oxford Academic | December 19, 2025

FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance 

CNN | December 12, 2025

IDWeek 2025: Real-world findings show lenacapavir effective in highly treatment-experienced people with HIV

EATG | December 6, 2025

Common water pill may help HIV medicines work faster and reduce inflammation

EATG | December 3, 2025

Long-term HIV control: Could this combination therapy be the key?

EATG | December 3, 2025

Merck's oral HIV treatment as effective as Gilead's Biktarv

The Jerusalem Post | November 24, 2025

Systemic inflammation in suppressed HIV similar after switch to 3-drug ART

EATG | November 22, 2025

Systemic Inflammation in Suppressed HIV Similar After Switch to 3-Drug ART

IDA | November 21, 2025

Merck's oral HIV treatment meets main goal in late-stage study

Reuters | November 19, 2025

Antibody drugs show promise for treating bird flu and HIV

Nature | November 5, 2025